Title : Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease.

Pub. Date : 2017 Mar

PMID : 28063023






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Vorapaxar is a first-in-class, protease-activated receptor-1 antagonist. vorapaxar coagulation factor II thrombin receptor Homo sapiens